Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJz Capital Regulatory News (JZCP)

Share Price Information for Jz Capital (JZCP)

Share Price is delayed by 15 minutes
Get Live Data
174.00    0.00 (0.00%)
Bid:
166.00
Ask:
182.00
Spread: 16.00 (9.639%)
Market Cap: £104.96m
JZCP Live PriceLast checked at - London Stock Exchange

Intraday Jz Capital Share Chart

US Acquisitions

25 Nov 2014 13:00

RNS Number : 9508X
JZ Capital Partners Ltd
25 November 2014
 



 

 

JZ CAPITAL PARTNERS EXPANDS PORTFOLIO WITH TWO U.S. ACQUISITIONS

25 November 2014

JZ Capital Partners Limited (LSE:JZCP.L or "JZCP"), the London listed private equity fund that invests in high quality US and European microcap companies, has expanded its US vertical portfolio by making two acquisitions alongside Edgewater Funds LP ("Edgewater").

JZCP and Edgewater invested $1.6 million each to acquire Action Products Marketing Corporation and ConShield Technologies Incorporated ("APMCS"), an infrastructure rehabilitation company headquartered in Johnston, Iowa. The company specialises in formulating and selling cementitious manhole and pipe rehabilitation products and provides the associated equipment used for application itself. The acquisition of APMCS is the third for the water infrastructure sub-vertical and the sixth for the water business overall.

JZCP and Edgewater also invested $1.31 million each to acquire PPM Information Solutions, Inc. ("PPMIS"), an anaesthesia billing software and service company. PPMIS operates two business lines, generating revenue from its proprietary billing and practice management software platform used by anaesthesia practices and other billing companies, and by providing outsourced medical billing services to anaesthesia practices. The acquisition of PPMIS is the third for the Bolder Healthcare Solutions vertical.

David Zalaznick, JZCP's Founder and Investment Adviser, commented:"Both acquisitions demonstrate the scope and expansion of our US portfolio and the strength of our investment pipeline. We are confident in the growth prospects of both companies and look forward to assisting them in reaching their full potential.

Both APMCS and PPMIS hold strong positions in their respective sectors and offer considerable opportunities to expand product range to appeal to their customers. We look forward to working with our co-investor Edgewater and the management teams of both companies over the coming years."

 

Ends

 

For further information:

 

Ed Berry / Kit Dunford +44 (0) 20 3727 1143

FTI Consulting

 

David Zalaznick +1 212 572 0800

Jordan/Zalaznick Advisers, Inc.

 

Andrew Maiden +44 (0) 1481 745368

JZ Capital Partners

 

About JZCP

 

JZCP is a London and Channel Islands listed private equity fund which invests in high quality US and European microcap companies. Its objective is to achieve a superior overall return comprised of a current yield and significant capital appreciation. JZCP receives investment advice from Jordan/Zalaznick Advisers, Inc. ("JZAI") which is led by David Zalaznick and Jay Jordan. They have worked together for 30 years and are supported by teams of investment professionals in New York, Chicago, London and Madrid. JZAI's experts work with the existing management of microcap companies to help build better businesses, create value and deliver strong returns for investors. JZCP also invests in mezzanine loans, first and second lien investments and other publicly traded securities. For more information please visit www.jzcp.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLELFLZFFZFBV
Date   Source Headline
18th Jun 20207:00 amPRNSuspension of NAV announcements
18th Jun 20207:00 amPRNAppointment and Retirement of Non-Executive Directors
18th Jun 20207:00 amPRNSuspension of NAV announcements
18th Jun 20207:00 amPRNAnnual Report and Financial Statements to 29.02.20
18th Jun 20207:00 amPRNAppointment and Retirement of Non-Executive Directors
22nd Apr 20202:31 pmPRNCompany Update
2nd Apr 20207:00 amPRNImpact of COVID-19
16th Mar 20207:00 amPRNSecondary Sale Update
5th Mar 202011:00 amPRNNet Asset Value(s)
24th Feb 20207:00 amPRNReal Estate Valuations
10th Feb 20207:00 amPRNReal Estate Valuations
3rd Feb 20208:40 amPRNNet Asset Value(s)
2nd Jan 20204:29 pmPRNDirector Declaration
23rd Dec 20195:45 pmPRNNet Asset Value(s)
16th Dec 20199:16 amPRNNet Asset Value(s)
27th Nov 20198:31 amPRNDirectorate Change
27th Nov 20197:00 amPRNHalf-year Report
26th Nov 201911:24 amPRNConfirmation of Half Year Results Announcement
31st Oct 20199:05 amRNSSecond Price Monitoring Extn
31st Oct 20199:00 amRNSPrice Monitoring Extension
30th Oct 20195:32 pmPRNPostponement of half year results
24th Oct 20192:58 pmPRNResults of EGM
21st Oct 20198:37 amPRNNet Asset Value(s)
21st Oct 20198:35 amPRNNotice of Half Year Results
4th Oct 20197:00 amPRNCirc re Investment Policy and Related Party Transactions
2nd Oct 20197:00 amPRNUpdate on Liquidity Plan for JZCP
23rd Sep 201910:37 amPRNNet Asset Value(s)
11th Sep 20194:51 pmPRNDirector Dealings
2nd Sep 20197:00 amPRNTotal Voting Rights
27th Aug 20197:00 amPRNResults of Tender Offer
21st Aug 20199:04 amPRNNet Asset Value(s)
19th Aug 20198:56 amPRNDirector Declaration
16th Aug 20191:30 pmPRNResults of EGM
26th Jul 20198:39 amPRNTender Offer, Article Amendments & EGM
22nd Jul 20199:02 amPRNNet Asset Value(s)
28th Jun 20197:00 amPRNQ1 2019 Interim Management Statement
27th Jun 20196:12 pmPRNDirectorate Change
27th Jun 20195:53 pmPRNShare Buybacks
27th Jun 20195:46 pmPRNResult of AGM
27th Jun 20194:16 pmPRNResult of EGM
30th May 201911:24 amPRNNotice of AGM
29th May 20197:00 amPRNNotice of EGM
21st May 20199:13 amPRNNet Asset Value(s)
8th May 20198:06 amPRNAnnual Report and Financial Statements to 28.02.19
29th Apr 20197:00 amPRNNotice of Full Year Results
23rd Apr 20199:14 amPRNNet Asset Value(s)
25th Mar 20197:00 amPRNNet Asset Value(s)
21st Feb 20199:29 amPRNNet Asset Value(s)
1st Feb 20198:58 amPRNVoting Rights and Capital
21st Jan 20199:25 amPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.